Portal Vein Thrombosis Might Develop by COVID-19 Infection or Vaccination: A Systematic Review of Case-Report StudiesMedicine Published on 2021-12-142022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] abdominal pain Anticoagulant available data Case report Comorbidity concerning COVID COVID-19 Diagnosis discharged etiology evaluate female infected patient Infection information Laboratory liver diseases males novel coronavirus disease organized performed portal Portal vein predict Prevalence reported review the patient the vaccine Therapies thrombosis thrombotic complication Treatment vaccination Vaccine Vaccines Vein Venous thrombosis Web of Science [DOI] 10.3389/fmed.2021.794599 PMC 바로가기 [Article Type] Medicine
The emergence, genomic diversity and global spread of SARS-CoV-2 Reviews Published on 2021-12-082022-10-05 Journal: Nature [Category] SARS, 변종, [키워드] available data China coronavirus COVID-19 COVID-19 pandemic disease Evolution fatality Genetic variation genomic global pandemic highlight increasingly information International pandemic reduced SARS-CoV-2 Spread Surveillance the SARS-CoV-2 virus transmission pattern Vaccines variant variants of concern viral spread virus Wuhan Wuhan, China [DOI] 10.1038/s41586-021-04188-6 [Article Type] Reviews
Effects of prolonged incubation period and centralized quarantine on the COVID-19 outbreak in Shijiazhuang, China: a modeling studyResearch Article Published on 2021-12-072022-10-28 Journal: BMC Medicine [Category] COVID-19, SARS, [키워드] 95% CI age analyzed Asymptomatic available data Characteristics Contact tracing COVID-19 COVID-19 outbreak cumulative diagnosed Diagnosis Effect Epidemic epidemiological Epidemiology evaluated identify implementation Incubation Incubation period indicated information Intervention Isolation likelihood Local male measure Monte Carlo method Non-pharmaceutical intervention nucleic acid occur occurred outbreak Patient quarantine reduce reduced Result secondary transmission SEIR SEIR model Sex suggested supplementary material symptomatic symptoms onset virus transmission were used [DOI] 10.1186/s12916-021-02178-z PMC 바로가기 [Article Type] Research Article
An age-structured SEIR model for COVID-19 incidence in Dublin, Ireland with framework for evaluating health intervention cost건강 중재 비용 평가를위한 프레임 워크와 함께 아일랜드 더블린에서 Covid-19 발병에 대한 연령 구조화 된 SEIR 모델Research Article Published on 2021-12-072022-09-10 Journal: PLoS ONE [Category] MERS, SARS, 변종, [키워드] adopted age approach assist association available data characterising Cohort Community Contact COVID-19 incidence described disease flexible form group groups Health in some incidence rate incidence rates Interaction interactions Intervention involved Ireland lockdown measure mental health mitigate morbidity outcome Predictive quantification Region retrospective SEIR Spread Strategy Uncertainty variant [DOI] 10.1371/journal.pone.0260632 PMC 바로가기 [Article Type] Research Article
Genomic Characterization of Host Factors Related to SARS-CoV-2 Infection in People with Dementia and Control Populations: The GR@ACE/DEGESCO StudyArticle Published on 2021-12-072022-10-30 Journal: Journal of Personalized Medicine [Category] COVID-19, [키워드] APOE added Analysis ApoE association available data characterization chromosomal region confirmed case Control COVID-19 COVID-19 disease COVID-19 prognosis COVID-19 severity Dementia disease disease severity Factor Genetic Genome-wide association study GR@ACE/DEGESCO GWAS Host implicated individual initiative involved locus LZTFL1 Meta-analysis outcome performed SARS-CoV-2 SARS-COV-2 infection sensitivity analysis SLC6A20 statistically significant stratified suggested susceptibility TYK2 with COVID-19 [DOI] 10.3390/jpm11121318 PMC 바로가기 [Article Type] Article
Integro-differential approach for modeling the COVID-19 dynamics – Impact of confinement measures in ItalyCOVID-19 역학 모델링을 위한 적분-차동 접근법 - 이탈리아의 격리 조치의 영향Article Published on 2021-12-012022-09-11 Journal: Computers in biology and medicine [Category] SARS, 변종, 치료기술, [키워드] adoption approach available data coefficient complicate condition conditions consequence Contagion Containment measure containment measures country COVID-19 COVID-19 epidemic COVID-19 pandemic criteria deaths detectable disorganized doctrine driven by Effectiveness English Epidemic Evolution failure Government health system health systems highlighting Impact incisive indication Infection involved Italian region Italian regions Italy lack limit management mathematical Mathematical modelling measure parameter parameters predict Propagation reactivity regions reliability robust SARS-CoV-2 security Spread stability Transmissibility Vaccinations Variability variant virus variants zone [DOI] 10.1016/j.compbiomed.2021.105013 PMC 바로가기 [Article Type] Article
The impact of the COVID-19 pandemic on autoimmune diagnostics in Europe: A lesson to be learnedReview article Published on 2021-12-012022-10-05 Journal: Autoimmunity reviews [Category] SARS, 진단, [키워드] affected autoantibody Autoantibody testing Autoimmune Autoimmune disease Autoimmune diseases available data Care characterized collected country COVID-19 COVID-19 pandemic decrease demonstrated diagnostics effective European European country First wave Greece Health Health care system IgA IgM initiative Laboratory less pandemic Patient positive positive result Practitioner reduction reduction in required Result second wave Switzerland [DOI] 10.1016/j.autrev.2021.102985 [Article Type] Review article
Groups 4 Health protects against unanticipated threats to mental health: Evaluating two interventions during COVID-19 lockdown among young people with a history of depression and lonelinessClinical Trial Published on 2021-12-012022-10-05 Journal: Journal of affective disorders [Category] SARS, 임상, [키워드] absence Analysis available data benefit CBT Cognitive behaviour therapy condition Control control group COVID-19 Depression evaluated Evaluating Follow-up follow-up assessments greater group Group memberships Intervention Isolation lockdown lockdown restriction loneliness Mental mental health offered outcome participant Participants PROTECT provided randomised reduced reported Research risk robust significantly Social identity social isolation Stressor Symptom Symptoms threat utility Well-being [DOI] 10.1016/j.jad.2021.08.029 PMC 바로가기 [Article Type] Clinical Trial
Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current EvidenceSARS-CoV-2 감염의 조기 치료를 위한 Fluvoxamine: 현재 증거 검토Review Published on 2021-12-012022-09-11 Journal: Drugs [Category] SARS, 비임상, 임상, [키워드] anti-inflammatory effect Anti-inflammatory effects appear available data breath Canada cause Clinical deterioration clinician condition controlled trials COVID-19 COVID-19 pandemic COVID-19 treatment COVID-19 treatment guidelines current cytokine production Decision making Dosing early treatment Efficacy fluvoxamine Infection inhibitor investigators knowledge long-lasting mechanism medication meeting morbidity morbidity and mortality NIH observational study potential mechanism potential mechanisms Psychiatric randomized clinical trial Randomized controlled trial receptor reduce Research review Safe SARS-CoV-2 SARS-COV-2 infection selective Sepsis Serotonin Treatment Trial USA [DOI] 10.1007/s40265-021-01636-5 PMC 바로가기 [Article Type] Review
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial입원한 성인 COVID-19(COV-BARRIER) 치료를 위한 바리시티닙의 효능 및 안전성: 무작위, 이중 맹검, 병행군, 위약 대조 3상 시험Clinical Trial Published on 2021-12-012022-09-11 Journal: The Lancet. Respiratory Medicine [Category] Fulltext, SARS, 임상, 치료법, 치료제, [키워드] 1:1 95% CI Abstract addition all-cause mortality anti-inflammatory properties antivirals Asia assigned available data Baricitinib baseline Care Combination company Corticosteroids country death defined Dexamethasone Disease progression dose double-blind Efficacy and safety enrolled Europe evaluate event exploratory Follow-up French frequencies Frequency hazard ratio High-flow oxygen hospitalised inhibitor intention-to-treat population Invasive mechanical ventilation Janus kinase Japanese Lilly material Mortality non-invasive ventilation North America Odds ratio oxygen parallel-group participant Participants Phase 3 phase 3 trial Placebo placebo group placebo-controlled placebo-controlled trial prevented primary endpoint progressed proportion randomised Randomly receive receiving reduced reduction in Registered Remdesivir risk risk difference safety analyses safety analysis safety population safety profile secondary endpoint selective Serious Adverse Event Serious Adverse Events serious infection serious infections South America Spanish Standard Standard of care study drug systemic corticosteroid systemic corticosteroids the placebo group the primary endpoint thromboembolic translation Treatment two groups venous thromboembolic were assessed with COVID-19 [DOI] 10.1016/S2213-2600(21)00331-3 PMC 바로가기 [Article Type] Clinical Trial